- Accueil >
- Publications >
- The histomolecular criteria established for adult anaplastic pilocytic astrocytoma are not applicable to the pediatric population
The histomolecular criteria established for adult anaplastic pilocytic astrocytoma are not applicable to the pediatric population
Auteurs
Albane Gareton, Arnault Tauziède-Espariat, Volodia Dangouloff-Ros, Alexandre Roux, Raphaël Saffroy, David Castel, Thomas Kergrohen, Fréderic Fina, Dominique Figarella-Branger, Mélanie Pagès, Franck Bourdeaut, François Doz, Stéphanie Puget, Christelle Dufour, Emmanuèle Lechapt, Fabrice Chrétien, Jacques Grill, Pascale Varlet
Résumé
Abstract
Pilocytic astrocytoma (PA) is the most common pediatric glioma, arising from a single driver MAPK pathway alteration. Classified as a grade I tumor according to the 2016 WHO classification, prognosis is excellent with a 10-year survival rate > 95% after surgery. However, rare cases present with anaplastic features, including an unexpected high mitotic/proliferative index, thus posing a diagnostic and therapeutic challenge. Based on small histomolecular series and case reports, such tumors arising at the time of diagnosis or recurrence have been designated by many names including pilocytic astrocytoma with anaplastic features (PAAF). Recent DNA methylation-profiling studies performed mainly on adult cases have revealed that PAAF exhibit a specific methylation signature, thus constituting a distinct methylation class from typical PA [methylation class anaplastic astrocytoma with piloid features—(MC-AAP)]. However, the diagnostic and prognostic significance of MC-AAP remains to be determined in children. We performed an integrative work on the largest pediatric cohort of PAAF, defined according to strict criteria: morphology compatible with the diagnosis of PA, with or without necrosis, ≥ 4 mitoses for 2.3 mm